7.24
+7.24
(0.00%)
As of January 24 at 3:56:32 PM EST. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
55,993,000.00
55,993,000.00
-1,772,000.00
117,590,000.00
73,067,000.00
Investing Cash Flow
-25,321,000.00
-25,321,000.00
-22,723,000.00
-28,848,000.00
-36,086,000.00
Financing Cash Flow
-22,720,000.00
-22,720,000.00
-24,522,000.00
-48,967,000.00
-55,908,000.00
End Cash Position
304,678,000.00
304,678,000.00
267,350,000.00
309,633,000.00
248,740,000.00
Capital Expenditure
-24,823,000.00
-24,823,000.00
-34,559,000.00
-40,467,000.00
-37,358,000.00
Issuance of Debt
49,825,000.00
49,825,000.00
--
44,874,000.00
34,918,000.00
Repayment of Debt
-10,000,000.00
-10,000,000.00
-29,000.00
-40,000,000.00
-35,000,000.00
Free Cash Flow
31,170,000.00
31,170,000.00
-36,331,000.00
77,123,000.00
35,709,000.00
3/31/2021 - 2/2/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0ND5.IL H. Lundbeck A/S
41.40
+0.04%
SGIOY Shionogi & Co., Ltd.
7.48
+2.47%
CYTH Cyclo Therapeutics, Inc.
0.8255
+0.55%
2196.HK Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
13.420
+0.75%
HLS.TO HLS Therapeutics Inc.
4.0300
+0.25%
ETON Eton Pharmaceuticals, Inc.
16.97
+1.80%
BIOA BioAge Labs, Inc.
5.26
-2.59%
AMRX Amneal Pharmaceuticals, Inc.
8.79
+1.27%
TAK Takeda Pharmaceutical Company Limited
13.32
+2.50%
BGM BGM Group Ltd.
10.65
+4.21%